Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 137

1.

Increased recurrences using intensity-modulated radiation therapy in the postoperative setting.

Turaka A, Li T, Sharma NK, Li L, Nicolaou N, Mehra R, Burtness B, Cohen RB, Lango MN, Horwitz EM, Ridge JA, Feigenberg SJ.

Am J Clin Oncol. 2010 Dec;33(6):599-603. doi: 10.1097/COC.0b013e3181c4c3cc.

PMID:
21063195
2.

Value of postoperative radiotherapy in patients with pathologic N1 neck disease.

J├Ąckel MC, Ambrosch P, Christiansen H, Martin A, Steiner W.

Head Neck. 2008 Jul;30(7):875-82. doi: 10.1002/hed.20794.

PMID:
18302275
3.
4.

Combined neck dissection and postoperative radiation therapy in the management of the high-risk neck: a matched-pair analysis.

Lundahl RE, Foote RL, Bonner JA, Suman VJ, Lewis JE, Kasperbauer JL, McCaffrey TV, Olsen KD.

Int J Radiat Oncol Biol Phys. 1998 Feb 1;40(3):529-34.

PMID:
9486600
5.

Delaying post-operative radiotherapy may increase risk of local recurrence in people with breast cancer.

Fortin A.

Cancer Treat Rev. 2003 Oct;29(5):441-3. Review. No abstract available.

PMID:
12972362
6.

Radiation treatment interruptions greater than one week and low hemoglobin levels (12 g/dL) are predictors of local regional failure after definitive concurrent chemotherapy and intensity-modulated radiation therapy for squamous cell carcinoma of the head and neck.

McCloskey SA, Jaggernauth W, Rigual NR, Hicks WL Jr, Popat SR, Sullivan M, Mashtare TL Jr, Khan MK, Loree TR, Singh AK.

Am J Clin Oncol. 2009 Dec;32(6):587-91. doi: 10.1097/COC.0b013e3181967dd0.

PMID:
19581794
7.

Intensity-modulated radiotherapy for oropharyngeal squamous cell carcinoma.

Mendenhall WM, Amdur RJ, Morris CG, Kirwan JM, Li JG.

Laryngoscope. 2010 Nov;120(11):2218-22. doi: 10.1002/lary.21144.

PMID:
20938964
8.

Initial clinical experience with helical tomotherapy for head and neck cancer.

Chen AM, Jennelle RL, Sreeraman R, Yang CC, Liu T, Vijayakumar S, Purdy JA.

Head Neck. 2009 Dec;31(12):1571-8. doi: 10.1002/hed.21123.

PMID:
19405087
9.

Marginal misses after postoperative intensity-modulated radiotherapy for head and neck cancer.

Chen AM, Farwell DG, Luu Q, Chen LM, Vijayakumar S, Purdy JA.

Int J Radiat Oncol Biol Phys. 2011 Aug 1;80(5):1423-9. doi: 10.1016/j.ijrobp.2010.04.011. Epub 2010 Jul 23.

PMID:
20656416
10.

Regional relapse after intensity-modulated radiotherapy for head-and-neck cancer.

Duprez F, Bonte K, De Neve W, Boterberg T, De Gersem W, Madani I.

Int J Radiat Oncol Biol Phys. 2011 Feb 1;79(2):450-8. doi: 10.1016/j.ijrobp.2009.10.028. Epub 2010 Apr 8.

PMID:
20381266
11.

Postoperative reirradiation for mucosal head and neck squamous cell carcinomas.

Iseli TA, Iseli CE, Rosenthal EL, Caudell JJ, Spencer SA, Magnuson JS, Smith AN, Carroll WR.

Arch Otolaryngol Head Neck Surg. 2009 Nov;135(11):1158-64. doi: 10.1001/archoto.2009.161.

PMID:
19917931
12.
13.

Improved dosimetric and clinical outcomes with intensity-modulated radiotherapy for head-and-neck cancer of unknown primary origin.

Chen AM, Li BQ, Farwell DG, Marsano J, Vijayakumar S, Purdy JA.

Int J Radiat Oncol Biol Phys. 2011 Mar 1;79(3):756-62. doi: 10.1016/j.ijrobp.2009.11.020. Epub 2010 Apr 24.

PMID:
20421143
14.

The impact of bilateral neck dissection on pattern of recurrence and survival in supraglottic carcinoma.

Weber PC, Johnson JT, Myers EN.

Arch Otolaryngol Head Neck Surg. 1994 Jul;120(7):703-6.

PMID:
8018320
15.

Misses and near-misses after postoperative radiation therapy for head and neck cancer: Comparison of IMRT and non-IMRT techniques in the CT-simulation era.

Chen AM, Farwell DG, Luu Q, Chen LM, Vijayakumar S, Purdy JA.

Head Neck. 2010 Nov;32(11):1452-9. doi: 10.1002/hed.21343.

PMID:
20146333
16.

Intensity-modulated radiotherapy for locally advanced cancers of the larynx and hypopharynx.

Daly ME, Le QT, Jain AK, Maxim PG, Hsu A, Loo BW Jr, Kaplan MJ, Fischbein NJ, Colevas AD, Pinto H, Chang DT.

Head Neck. 2011 Jan;33(1):103-11. doi: 10.1002/hed.21406.

PMID:
20848427
17.

Efficacy and toxicity of chemoradiotherapy using intensity-modulated radiotherapy for unknown primary of head and neck.

Sher DJ, Balboni TA, Haddad RI, Norris CM Jr, Posner MR, Wirth LJ, Goguen LA, Annino D, Tishler RB.

Int J Radiat Oncol Biol Phys. 2011 Aug 1;80(5):1405-11. doi: 10.1016/j.ijrobp.2010.04.029. Epub 2010 Dec 20.

PMID:
21177045
18.

Predictive factors of local-regional recurrences following parotid sparing intensity modulated or 3D conformal radiotherapy for head and neck cancer.

Feng M, Jabbari S, Lin A, Bradford CR, Chepeha DB, Teknos TN, Worden FP, Tsien C, Schipper MJ, Wolf GT, Dawson LA, Eisbruch A.

Radiother Oncol. 2005 Oct;77(1):32-8. Epub 2005 Sep 8.

PMID:
16154219
19.

Evaluation of the planning target volume in the treatment of head and neck cancer with intensity-modulated radiotherapy: what is the appropriate expansion margin in the setting of daily image guidance?

Chen AM, Farwell DG, Luu Q, Donald PJ, Perks J, Purdy JA.

Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):943-9. doi: 10.1016/j.ijrobp.2010.07.017. Epub 2010 Oct 6.

PMID:
20932680
20.

Factors affecting cancer recurrence after microvascular flap reconstruction of the head and neck.

Roostaeian J, Suh JD, Sercarz JA, Abemayor E, Lee JT, Blackwell KE.

Laryngoscope. 2005 Aug;115(8):1391-4.

PMID:
16094111

Supplemental Content

Support Center